Search Results
HEN: Pharmacoeconomics (Sub-Topic)

41,989 Total downloads

Viewing: 1 - 50 of 342 papers

1.

The Globalization of Innovation: Pharmaceuticals: Can India and China Cure the Global Pharmaceutical Market

Number of pages: 67 Posted: 11 Jun 2008 Last Revised: 23 Feb 2014
Working Paper Series
Center for Entrepreneurship and Research Commercialization, Pratt School of Engineering, Cornell University - School of Industrial and Labor Relations, Duke University - Department of Sociology - Director, Center on Globalization, Governance & Competitiveness, Harvard University - Labor and Worklife Program and BusinessWeek
Downloads 2,786
2.

Killer Acquisitions

Number of pages: 106 Posted: 12 Sep 2018 Last Revised: 22 Apr 2020
Working Paper Series
London Business School, Yale School of Management and Yale School of Management
Downloads 2,658
3.

Drug Regulation in the Philippines

Number of pages: 14 Posted: 24 Apr 2009
Working Paper Series
Masters in Public Administration
Downloads 1,682
4.

Paying for Delay: Pharmaceutical Patent Settlement as a Regulatory Design Problem

New York University Law Review, Vol. 81, p. 1553, 2006, Columbia Law and Economics Working Paper No. 306
Number of pages: 68 Posted: 21 Oct 2006 Last Revised: 28 Dec 2013
Accepted Paper Series
New York University School of Law
Downloads 1,624
5.

May Your Drug Price Be Evergreen

Oxford Journal of Law and the Biosciences (2018)
Number of pages: 58 Posted: 31 Oct 2017 Last Revised: 28 Apr 2019
Accepted Paper Series
University of California Hastings Law
Downloads 1,419
6.

Pharmaceutical Innovation

KSG Working Paper No. RWP07-004, AEI-Brookings Joint Center Working Paper No. 07-19
Number of pages: 59 Posted: 06 Feb 2007
Working Paper Series
Harvard University - Harvard Kennedy School (HKS)
Downloads 1,147
7.

The Indian Pharmaceutical Industry - an Overview of Internal Efficiencies Using Data Envelopment Analysis

Number of pages: 23 Posted: 11 May 2004
Working Paper Series
Indian Institute of Management (IIM), Calcutta and Indian Institute of Technology Kanpur
Downloads 970
8.

The Health Impact Fund: Better Pharmaceutical Innovations at Much Lower Prices

INCENTIVES FOR GLOBAL PUBLIC HEALTH: PATENT LAW AND ACCESS TO MEDICINES, Thomas Pogge, Matthew Rimmer, and Kim Rubenstein, (eds.), Cambridge: Cambridge University Press, 2010
Number of pages: 26 Posted: 09 Jul 2009
Accepted Paper Series
Yale Philosophy Department
Downloads 888
9.

Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents

AEI-Brookings Joint Center Working Paper No. 03-7
Number of pages: 35 Posted: 16 Jul 2003
Working Paper Series
University of Pennsylvania - Health Care Systems Department and Office of Health Economics
Downloads 841
10.

European Pharmaceutical Price Regulation, Firm Profitability, and R&D Spending

Number of pages: 38 Posted: 27 Sep 2006
Working Paper Series
University of Connecticut - Department of Finance and University of North Carolina (UNC) at Chapel Hill

Multiple version iconThere are 2 versions of this paper

Downloads 812
11.

Do National Patent Laws Stimulate Domestic Innovation in a Global Patenting Environment? A Cross-Country Analysis of Pharmaceutical Patent Protection, 1978-2002

Review of Economics and Statistics, Vol. 89, No. 3, 2007
Number of pages: 18 Posted: 28 Oct 2007 Last Revised: 08 Jun 2014
Accepted Paper Series
Downloads 740
12.

The Invention of an Investment Incentive for Pharmaceutical Innovation

The Journal of World Intellectual Property (2012) Vol. 15, No. 5-6., pp. 1-60
Number of pages: 60 Posted: 20 Jan 2013 Last Revised: 19 Oct 2015
Accepted Paper Series
Nirma University - Institute of Law
Downloads 657
13.

Physician Agency and Adoption of Generic Pharmaceuticals

Number of pages: 52 Posted: 02 Jul 2011
Working Paper Series
University of Tokyo
Downloads 597
14.

Valuation of Intangible Assets: Estimating Late-Stage Development Cost of Pharmaceutical R&D

Number of pages: 52 Posted: 12 Sep 2007
Working Paper Series
Institute of Leadership and Management in Health - Kingston University and Henley Management College - Henley Centre for Value Improvement (HCVI)
Downloads 515
15.

Legal Fallacies of Antipsychotic Drugs

Journal of the American Academy of Psychiatry and the Law, Vol. 35, p. 235, 2007
Number of pages: 12 Posted: 06 Dec 2006 Last Revised: 28 Mar 2008
Accepted Paper Series
affiliation not provided to SSRN, University of Rochester Medical Center, University of Rochester, University of Rochester Medical Center and Mendota Mental Health Institute
Downloads 510
16.

Global Competitiveness of Indian Pharmaceutical Industry: Trends and Strategies

ISID Working Paper No. 2006/05
Number of pages: 68 Posted: 02 Dec 2009
Working Paper Series
Central University of Gujarat

Multiple version iconThere are 2 versions of this paper

Downloads 509
17.

Pharmaceuticals, Political Money, and Public Policy: A Theoretical and Empirical Agenda

Journal of Law, Medicine and Ethics, Vol. 14, No. 3, 2013, Forthcoming
Number of pages: 26 Posted: 11 Jul 2013
Accepted Paper Series
University of Texas - Pan American
Downloads 508
18.

Entry and Competition in Generic Biologics

Managerial and Decision Economics, 2007
Number of pages: 39 Posted: 17 Jul 2007 Last Revised: 20 Sep 2014
Accepted Paper Series
Duke University - Department of Economics, Duke University - Fuqua School of Business and Duke University - Medical Center
Downloads 477
19.

Pathways Across the Valley of Death: Novel Intellectual Property Strategies for Accelerated Drug Discovery

Yale Journal of Health Policy, Law, and Ethics, Vol. 8, No. 1, 2008
Number of pages: 37 Posted: 17 Jan 2008
Accepted Paper Series
Duke University School of Law, Duke University School of Law, The National Academies - National Academy of Sciences (NAS) and Independent
Downloads 459
20.

The Effects of Detailing on Prescribing Decisions Under Quality Uncertainty

Quantitative Marketing and Economics, Vol.8, No. 2, pp.123-165, June 2010
Number of pages: 51 Posted: 29 Aug 2007 Last Revised: 06 Jul 2010
Accepted Paper Series
Johns Hopkins University - Carey Business School and New York University (NYU) - Leonard N. Stern School of Business
Downloads 459
21.

Patent Amendment Act 2005: Its Effect on Indian Pharmaceutical Company

Number of pages: 14 Posted: 17 Jul 2009
Working Paper Series
West Bengal National University of Juridical Sciences
Downloads 458
22.

The Effects of Publicity on Demand: The Case of Anti-Cholesterol Drugs

Published in Marketing Science 35(1):158-181, 2016, Rotman School of Management Working Paper No. 1782055
Number of pages: 54 Posted: 09 Mar 2011 Last Revised: 08 May 2020
Working Paper Series
Johns Hopkins University - Carey Business School, HEC Montreal, University of Toronto - Rotman School of Management and York University
Downloads 436
23.

The Concept of an Agreement and Beyond: How to Block Parallel Imports of Pharmaceuticals to Protect the Heart of Competition

EC COMPETITION LAW A CRITICAL ASSESSMENT, Giuliano Amato, Claus-Dieter Ehlermann, eds., pp. 81-142, Hart Publishing, 2007
Number of pages: 62 Posted: 06 Dec 2007
Accepted Paper Series
European University Institute
Downloads 413
24.

A 'Calibrated Approach': Pharmaceutical FDI and Evolution of the Patent Law in India

Number of pages: 19 Posted: 20 Nov 2007 Last Revised: 13 Mar 2013
Working Paper Series
Independent and U.S. International Trade Commission
Downloads 376
25.

Drug Rebates Do Not Increase Costs to Consumers

Number of pages: 8 Posted: 08 Jun 2018
Working Paper Series
University of Illinois at Chicago - School of Public Health and The Jack Kemp Foundation
Downloads 336
26.

Review of the Literature on Reference Pricing

Universitat Pompeu Fabra Economics WP No. 362
Number of pages: 49 Posted: 21 Jul 1999
Working Paper Series
Universitat Pompeu Fabra - Department of Economics and Business (DEB) and Universitat Pompeu Fabra - Faculty of Economic and Business Sciences
Downloads 334
27.

Financing Drug Research: What are the Issues?

2008 Industry Studies Conference Paper
Number of pages: 28 Posted: 21 May 2008
Working Paper Series
Centre for Economic Policy Research (CEPR)
Downloads 333
28.

Generic Entry into a Regulated Pharmaceutical Market

iHEA 2007 6th World Congress: Explorations in Health Economics Paper
Number of pages: 25 Posted: 11 Jun 2007
Working Paper Series
Universitat Pompeu Fabra - Faculty of Economic and Business Sciences, Universitat Pompeu Fabra - Faculty of Economic and Business Sciences and University of Barcelona
Downloads 324
29.

The Impact of Direct-to-Consumer Advertising of Prescription Drugs on Physician Visits and Drug Requests: Empirical Findings and Public Policy Implications

International Journal of Research in Marketing, Forthcoming, Johnson School Research Paper Series No. 26-11
Number of pages: 40 Posted: 11 Apr 2011 Last Revised: 19 Sep 2014
Accepted Paper Series
Purdue University - Krannert School of Management and Cornell University - Samuel Curtis Johnson Graduate School of Management
Downloads 302
30.

Entry in the ADHD Drugs Market: Welfare Impact of Generics and Me-Toos

Journal of Industrial Economics, 61(2), 339-392, June 2013
Number of pages: 46 Posted: 09 May 2009 Last Revised: 01 Jul 2015
Working Paper Series
University of East Anglia (UEA) - School of Economic and Social Studies and Florida State University
Downloads 300
31.

Experts' Agency Problems: Evidence from the Prescription Drug Market in Japan

RAND Journal of Economics, Forthcoming
Number of pages: 26 Posted: 07 Dec 2006
Accepted Paper Series
University of Tokyo
Downloads 294
32.

The Food and Drug Administration's Evolving Regulation of Press Releases: Limits and Challenges

Food and Drug Law Journal, Vol. 61, p. 623, 2006
Number of pages: 31 Posted: 25 Apr 2007
Accepted Paper Series
Arnold & Porter, Southern Methodist University - Dedman School of Law and Pharmaceutical Research and Manufacturers of America (PhRMA)
Downloads 288
33.

Cost/Effective Analysis of Anti-HPV Vaccination Programme in Italy: A Multi-Cohort Markov Model

Number of pages: 18 Posted: 07 Feb 2007
Working Paper Series
Institute of Leadership and Management in Health - Kingston University, affiliation not provided to SSRN and Henley Management College - Henley Centre for Value Improvement (HCVI)
Downloads 275
34.

Estimating the Cost of Strategic Entry Delay in Pharmaceuticals: The Case of Ambien CR

Number of pages: 30 Posted: 17 Jun 2015 Last Revised: 28 Sep 2016
Working Paper Series
University of Chicago - Booth School of Business
Downloads 274
35.

The Private Sale of Cancer Drugs in Ontario's Public Hospitals: Tough Issues at the Public/Private Interface in Health Care

McGill Journal of Law and Health, April 30, 2007
Number of pages: 29 Posted: 12 Apr 2007 Last Revised: 17 Nov 2011
Accepted Paper Series
University of Ottawa - Faculty of Law and University of Ottawa - Common Law Section
Downloads 270
36.

Open Source Drug Discovery: Finding a Niche (or Maybe Several)

Number of pages: 28 Posted: 30 Mar 2008
Working Paper Series
University of California, Berkeley
Downloads 266
37.

Intellectual Property and the Availability of Pharmaceuticals in Poor Countries

Center for Global Development Working Paper No. 5
Number of pages: 43 Posted: 12 Jul 2007
Working Paper Series
University of California, Berkeley, College of Natural Resources, Department of Agricultural & Resource Economics (Deceased)
Downloads 265
38.

Essential Drugs

KSG Working Paper No. RWP07-003
Number of pages: 11 Posted: 06 Feb 2007
Working Paper Series
Harvard University - Harvard Kennedy School (HKS)
Downloads 264
39.

Diffusion of New Pharmaceutical Drugs in Developing and Developed Nations

Stanford University Graduate School of Business Research Paper No. 1950
Number of pages: 34 Posted: 17 Nov 2006
Working Paper Series
Stanford University - Graduate School of Business, University of Central Florida - College of Business Administration and University of Chicago
Downloads 257
40.

Entry Threats and Pricing in the Generic Drug Industry

US Federal Trade Commission Bureau of Economics Working Paper No. 301
Number of pages: 40 Posted: 08 Jun 2010 Last Revised: 11 Oct 2012
Working Paper Series
Charles River Associates and Government of the United States of America - Federal Trade Commission
Downloads 255
41.

Pharmaceutical Promotion and Gp Prescription Behaviour

CPB Discussion Paper No 30
Number of pages: 44 Posted: 24 Jun 2004
Working Paper Series
University of Bristol - Department of Economics, Ministry of Health, Welfare and Sports, CPB Netherlands Bureau for Economic Policy Analysis and CPB Netherlands Bureau of Economic Policy Analysis

Multiple version iconThere are 2 versions of this paper

Downloads 247
42.

Pharmaceutical Research Strategies

Tinbergen Institute Discussion Paper No. 08-022/3
Number of pages: 13 Posted: 05 Mar 2008
Working Paper Series
Erasmus University Rotterdam (EUR) and McKinsey & Co. Inc.
Downloads 244
43.

"Generic Entry and the Pricing of Pharmaceuticals"

NBER Working Paper No. w5306
Number of pages: 24 Posted: 19 Jun 2000 Last Revised: 20 Sep 2014
Working Paper Series
Harvard Medical School and UMBC, Department of Public Policy
Downloads 240
44.

Price Sensitivity of Demand for Prescription Drugs: Exploiting a Regression Kink Design

Univ. of Aarhus Dept. of Economics Working Paper No. 2010-3
Number of pages: 47 Posted: 27 Jan 2010
Working Paper Series
Aarhus University - Department of Economics and Business, Aarhus University - Department of Economics and Aarhus University
Downloads 240
45.

To Study the Major Factors that Influence the Prescription Pattern of Doctors

Number of pages: 7 Posted: 28 Aug 2014
Working Paper Series
Sam Higginbottom Institute of Agriculture, Technology and Sciences
Downloads 230
46.

How to Project Patient Persistency

Foresight: The International Journal of Applied Forecasting, Vol. 8, pp. 31-35, 2007
Number of pages: 10 Posted: 03 Nov 2007
Accepted Paper Series
University of Pennsylvania - Marketing Department, University of Pennsylvania - Marketing Department and London Business School
Downloads 222
47.

Beyond 80%: Are There New Ways of Increasing Vaccination Coverage? Evaluation of CCT Programs in Mexico and Nicaragua

iHEA 2007 6th World Congress: Explorations in Health Economics Paper
Number of pages: 54 Posted: 22 Jun 2007
Working Paper Series
The World Bank, University of Colorado at Boulder and Middlebury College - Department of Economics
Downloads 215
48.

Generic Entry in a Regulated Pharmaceutical Market

Japanese Economic Review, Forthcoming
Number of pages: 24 Posted: 20 Feb 2009
Accepted Paper Series
University of Tokyo

Multiple version iconThere are 2 versions of this paper

Downloads 215
49.

Regulation, Generic Competition and Pharmaceutical Prices: Theory and Evidence from a Natural Experiment

NHH Dept. of Economics Discussion Paper No. 39/2007
Number of pages: 32 Posted: 11 Feb 2010
Working Paper Series
Norwegian School of Economics (NHH) - Department of Economics, Foundation for Research in Economics and Business Administration (SNF) and University of Minho - Economic Policies Research Unit (NIPE)
Downloads 200
50.

Estimating Cost Savings from Early Cancer Diagnosis

Data 2(3) (2017) 30
Number of pages: 22 Posted: 28 May 2017 Last Revised: 03 Apr 2019
Accepted Paper Series
Quantigic Solutions LLC, Two29 Consulting LLC and Duke-NUS Medical School - Centre for Computational Biology
Downloads 197